HR 6197, the Health Tech Investment Act, establishes a new payment category under Medicare for algorithm-based healthcare services (like AI tools used in diagnosis or treatment) starting January 1, 2026. It requires Medicare to pay based on manufacturer-provided costs (including software, staff, and overhead) for these services and prohibits removing them from the special payment category for at least five years after initial payment. This directly affects Medicare beneficiaries (through coverage), healthcare providers (who deliver these services), and AI/algorithm service manufacturers (who receive reimbursement). The bill ensures these new technologies get fair payment while gathering sufficient claims data before potentially moving them to standard payment categories.
This resolution designates the week of September 14-20, 2025, as "Telehealth Awareness Week" to highlight the role of telehealth in expanding access to healthcare. It recognizes telehealth's importance for rural communities, seniors, and patients with mobility barriers, noting its increased use in Medicare programs. The Senate urges stakeholders to raise awareness about telehealth benefits, share resources for providers and patients, and promote continued access to telehealth services. As a symbolic resolution, it does not create new laws or alter healthcare policies but aims to foster broader recognition of telehealth’s value.
This bill would require health insurance plans that cover obstetrical services to also cover fertility treatment, including procedures like in vitro fertilization, artificial insemination, embryo preservation, and related medications. It applies to private insurance plans, federal employee health benefits, TRICARE, VA benefits, Medicaid programs, and Medicare. The law mandates coverage regardless of whether a patient has been diagnosed with infertility, prohibits cost-sharing exceeding what's applied to other medical services, and requires plans to provide clear notice about the coverage to participants. The goal is to make fertility treatment more accessible and affordable for people who need it.
SRES 385 is a Senate resolution recognizing suicide as a serious public health issue in the U.S. and supporting the designation of September as "National Suicide Prevention Month." It does not create new laws or funding but formally acknowledges suicide statistics (e.g., 49,000 annual deaths, 1 death every 11 minutes) and emphasizes suicide prevention as a priority. The resolution promotes awareness that suicide has no single cause and encourages access to mental health services, without specifying policy changes or requiring government action. It is a symbolic gesture by the Senate, not a binding legislative measure.
This resolution expresses congressional support for designating April 30, 2025, as "National Adult Hepatitis B Vaccination Awareness Day." It highlights that only 30% of U.S. adults are vaccinated against hepatitis B despite the vaccine being 95% effective, and emphasizes the need to increase adult vaccination rates - particularly among high-risk groups like people who inject drugs and communities disproportionately affected by the virus. The resolution encourages adults to get tested and vaccinated, links diagnosed individuals to care, and promotes awareness to reduce hepatitis B-related liver cancer and death. It does not create new laws but aims to raise public and provider awareness about existing vaccination recommendations.
S 2793, the Ensuring Access to Essential Providers Act of 2025, requires Medicare Advantage (MA) plans to include specific types of community health providers in their networks. It directly affects MA organizations serving seniors and people with disabilities, mandating they include enough providers serving low-income, rural, or health professional shortage areas to ensure "reasonable and timely access." Key provisions include requiring MA plans to contract with available essential community providers (like Federally Qualified Health Centers, rural hospitals, and Indian Health Service facilities), justify if they cannot meet this standard, and pay Federally Qualified Health Centers appropriately. The bill aims to improve access for vulnerable populations without mandating coverage for specific medical procedures.
The Restoring Essential Healthcare Act repeals a provision that blocked Medicaid payments to certain healthcare providers. Specifically, it removes a restriction from Public Law 119-21 that prevented Medicaid from paying "prohibited entities" for services provided between the law's enactment and this bill's effective date. Payments for those services will now be made retroactively, as if the restriction had never existed. This directly affects Medicaid programs and the healthcare providers previously excluded from receiving these payments.
HR 5526, the Biosimilar Red Tape Elimination Act, streamlines the U.S. Food and Drug Administration’s (FDA) process for approving biosimilar drugs that can be used interchangeably with brand-name biologic medications. It establishes a 60-day transition period after enactment to clarify when biosimilars are deemed "interchangeable" with reference drugs, preserving existing exclusivity periods for products licensed before the law’s passage. This affects pharmaceutical manufacturers developing biosimilars, the FDA (which must update its guidance within 18 months), and healthcare systems seeking lower-cost treatment options. The bill removes redundant language from existing laws and ensures the FDA’s approval standards for biosimilars remain unchanged, focusing on regulatory clarity rather than altering drug safety or efficacy requirements.
This bill allows states to create new Medicaid demonstration projects that give enrollees an electronic benefits card for primary care and medications, with unused funds converted to cash annually. Participants could also enroll in state-determined catastrophic insurance for coverage beyond the card's limits. The projects must not increase federal spending compared to standard Medicaid and prohibit abortion coverage except when necessary to save a mother's life or in cases of rape or incest. It directly affects Medicaid enrollees in states that adopt such projects, granting states more flexibility in program design.
HRES 960 is a symbolic resolution expressing congressional support for designating November 2025 as "National Lung Cancer Awareness Month." It also supports related observances like "National Women's Lung Cancer Awareness Week" and "National Lung Cancer Screening Day." The resolution aims to promote public awareness, education, and efforts around early detection, screening, and treatment of lung cancer - highlighting that lung cancer causes more U.S. deaths annually than several other cancers combined. It specifically emphasizes increasing access to screening and addressing disparities affecting minorities, non-smokers, and veterans, though the resolution itself does not create new laws or funding.